Discharge and aftercare in chronic lung disease of the newborn

Seminars in Neonatology

Volumn 8, Issue 2, 2003, Pages 117-126

  Primhak, R A ^a  

^a SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Bronchopulmonary dysplasia; Chronic lung disease; Oximetry; Oxygen inhalation therapy

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLOROTHIAZIDE; DIURETIC AGENT; FLUTICASONE PROPIONATE; PALIVIZUMAB; SPIRONOLACTONE; STEROID;

BODY HEIGHT; CALORIC INTAKE; CATCH UP GROWTH; CHRONIC LUNG DISEASE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; EXERCISE TOLERANCE; HEALTH CARE PERSONNEL; HOME CARE; HOSPITAL DISCHARGE; HUMAN; INFANT NUTRITION; INFLUENZA VACCINATION; LONG TERM CARE; LUNG FUNCTION; META ANALYSIS; NEWBORN DISEASE; NEWBORN MONITORING; NEWBORN MORBIDITY; NEWBORN MORTALITY; OXIMETRY; OXYGEN CONSUMPTION; OXYGEN SATURATION; OXYGEN SUPPLY; OXYGEN THERAPY; PARENTAL BEHAVIOR; RESUSCITATION; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING; VIRUS INFECTION;

EID: 0037693829     PISSN: 10842756     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1084-2756(02)00136-7     Document Type: Article

References (74)

1. Northway W, Rosan R, Porter D. Pulmonary disease following respiratory therapy of hyaline membrane disease: bronchopulmonary dysplasia. New Engl J Med 1967;276:357-8.
2. Hyde I, English RE, Williams JD. The changing pattern of chronic lung disease of prematurity. Arch Dis Child 1989; 64:448-51.
3. Shennan A, Dunn M, Ohlsson A et al. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988; 82:527-32.
4. Giffin F, Greenough A, Yuksel B. Does the duration of oxygen dependence after birth influence subsequent respiratory morbidity? Eur J Pediatr 1994;153:34-7.
5. Greenough A, Giffin FJ, Yuksel B et al. Respiratory morbidity in young school children born prematurely-chronic lung disease is not a risk factor? Eur J Pediatr 1996;155:823-6.
6. Greenough A, Alexander J, Burgess S et al. Home oxygen status and rehospitalisation and primary care requirements of infants with chronic lung disease. Arch Dis Child 2002; 86:40-3.
7. Kennedy JD, Edward LJ, Bates DJ et al. Effects of birthweight and oxygen supplementation on lung function in late childhood in children of very low birth weight. Pediatr Pulmonol 2000;30:32-40.
8. Hunt CE, Corwin MJ, Lister G et al. Longitudinal assessment of hemoglobin oxygen saturation in healthy infants during the first 6 months. J Pediatr 1999;135:580-6.
9. Horemuzova E, Katz-Salamon M, Milerad J. Breathing patterns, oxygen and carbon dioxide levels in sleeping healthy infants during the first nine months after birth. Acta Paediatr 2000;89:1284-9.
10. Weitzenblum E, Chaouat A. Hypoxic pulmonary hypertension in man: what minimum duration of hypoxaemia is required? Eur Respir J 2001;18:251-3.
11. Iles R, Edmunds A. Prediction of early outcome in resolving chronic lung disease of prematurity after discharge from hospital. Arch Dis Child 1996;74:304-8.
12. Moyer-Mileur LJ, Nielson DW, Pfeffer KD et al. Eliminating sleep-associated hypoxemia improves growth in infants with bronchopulmonary dysplasia. Pediatrics 1996;98:779-83.
13. Simoes EA, Rosenberg AA, King SJ et al. Room air challenge: prediction for successful weaning of oxygen-dependent infants. J Perinatol 1997;17:125-9.
14. Vermeulen MJ, Weening FT, Battistutta D et al. Awake daytime oximetry measurements in the management of infants with chronic lung disease. J Paediatr Child Health 1999;35:553-7.
15. Poets CF. When do infants need additional inspired oxygen? A review of the current literature. Pediatr Pulmonol 1998; 26:424-8.
16. STOP-ROP Multicenter Study Group. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized controlled trial. New Engl J Med 2000;105:295-310.
17. Tin W, Milligan D, Pennefather P et al. Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child Fetal Neonatal Ed 2001;84:F106-10.
18. Wiltshire N, Kendrick A, Catterall J. Home oximetry studies for diagnosis of sleep apnea/hypopnea syndrome. Chest 2001;120:384-9.
19. Thilo E, Andersen D, Wasserstein M et al. Saturation by pulse oximetry: comparison of the results obtained by instruments of different brands. J Pediatr 1993;122:620-6.
20. Weber M, Palmer A, Oparaugo A et al. Comparison of nasal prongs and nasopharyngeal catheter for the delivery of oxygen to children with hypoxaemia because of a lower respiratory tract infection. J Pediatr 1995;127:378-83.
21. Fan L, Voyles J. Determination of inspired oxygen delivered by nasal cannula in infants with chronic lung disease. J Pediatr 1983;103:923-5.
22. Werthammer J, Brown E, Neff R et al. Sudden infant death syndrome in infants with bronchopulmonary dysplasia. Pediatrics 1982;69:301-4.
23. Gray P, Rogers Y. Are infants with bronchopulmonary dysplasia at risk for sudden infant death syndrome? Pediatrics 1994;93:774-7.
24. Duffty P, Bryan M. Home apnea monitoring in 'Near Miss' sudden infant death syndrome (SIDS) and in siblings of SIDS victims. Pediatrics 1982;70:69-74.
25. Kinney JS, Robertsen CM, Johnson KM et al. Seasonal respiratory viral infections. Impact on infants with chronic lung disease following discharge from the neonatal intensive care unit. Arch Pediatr Adolesc Med 1995;149:81-5.
26. Chidekel AS, Rosen CL, Bazzy AR. Rhinovirus infection associated with serious lower respiratory illness in patients with bronchopulmonary dysplasia. Pediatr Infect Dis J 1997; 16:43-7.
27. IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics 1998;102:531-7.
28. Thomas M, Bedford-Russell A, Sharland M. Hospitalisation for RSV infection in ex-preterm infants-implications for use of RSV immune globulin. Arch Dis Child 2000;83:122-7.
29. Clark S, Beresford M, Subhedar N et al. Respiratory syncytial virus infection in high risk infants and the potential impact of prophylaxis in a United Kingdom cohort. Arch Dis Child 2000;83:313-6.
30. Singer LT, Davillier M, Preuss L et al. Feeding interactions in infants with very low birth weight and bronchopulmonary dysplasia. J Dev Behav Pediatr 1996;17:69-76.
31. Kurzner S, Garg M, Bautista D et al. Growth failure in bronchopulmonary dysplasia. Nutrition and elevated resting metabolic expenditure. Pediatrics 1988;81:379-84.
32. Brunton JA, Saigal S, Atkinson SA. Growth and body composition in infants with bronchopulmonary dysplasia up to 3 months corrected age: a randomized trial of a highenergy nutrient-enriched formula fed after hospital discharge. J Pediatr 1998;133:340-5.
33. Fewtrell MS, Adams C, Wilson DC et al. Randomized trial of high nutrient density formula versus standard formula in chronic lung disease. Acta Paediatr 1997;86:577-82.
34. Fuloria M, Hiatt D, Dillard RG. Gastroesophageal reflux in very tow birth weight infants: association with chronic lung disease and outcomes through 1 year of age. J Perinatol 2000;20:235-9.
35. Jolley SG, Halpern CT, Sterling CE et al. The relationship of respiratory complications from gastroesophageal reflux to prematurity in infants. J Pediatr Surg 1990;25:755-7.
36. Sindel BD, Maisels MJ, Ballantine TV. Gastroesophageal reflux to the proximal esophagus in infants with bronchopulmonary dysplasia. Am J Dis Child 1989;143:1103-6.
37. Beresford M, Primhak R, Subhedar N et al. Randomised double blind placebo controlled trial of inhaled fluticasone proprionate in infants with chronic lung disease. Arch Dis Child 2002;87:F62-3.
38. Brion LP, Primhak RA. Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev 2000; computer file: CD001453.
39. Brion LP, Primhak RA, Ambrosio-Perez I. Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev 2000; computer file: CD001817.
40. Brion LP, Primhak RA, Yong W. Aerosolized diuretics for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev 2000; computer file: CD001694.
41. Kao L, Durand D, McCrea R et al. Randomized trial of long-term diuretic therapy for infants with oxygen-dependent bronchopulmonary dysplasia. J Pediatr 1994; 124:772-81.
42. Berman W Jr., Katz R, Yabek SM et al. Long-term follow-up of bronchopulmonary dysplasia. J Pediatr 1986;109:45-50.
43. Gray PH, Burns YR, Mohay HA et al. Neurodevelopmental outcome of preterm infants with bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed 1995; 73:F128-34.
44. Gregoire MC, Lefebvre F, Glorieux J. Health and developmental outcomes at 18 months in very preterm infants with bronchopulmonary dysplasia see comments. Pediatrics 1998;101:856-60.
45. Palta M, Sadek-Badawi M, Evans M et al. Functional assessment of a multicenter very low-birth-weight cohort at age 5 years. Newborn lung project. Arch Pediatr Adolesc Med 2000;154:23-30.
46. Singer L, Yamashita T, Lilien L et al. Longitudinal study of developmental outcome of infants with bronchopulmonary dysplasia and very low birth weight. Pediatrics 1997; 100:987-93.
47. Luchi JM, Bennett FC, Jackson JC. Predictors of neuro-developmental outcome following bronchopulmonary dysplasia. Am J Dis Child 1991;145:813-7.
48. Zanardo V, Freato F. Home oxygen therapy in infants with bronchopulmonary dysplasia: assessment of parental anxiety. Early Hum Dev 2001;65:39-46.
49. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 1980;93:391-8.
50. Eber E, Zach M. Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy). Thorax 2001; 56:317-33.
51. Baraldi E, Filippone M, Trevisanuto D et al. Pulmonary function until two years of life in infants with broncho-pulmonary dysplasia. Am J Respir Crit Care Med 1997; 155:149-55.
52. Gerhardt T, Hehre D, Feller R et al. Serial determination of pulmonary function in infants with chronic lung disease. J Pediatr 1987;110:448-56.
53. Doyle LW, Ford GW, Olinsky A et al. Bronchopulmonary dysplasia and very low birth-weight: lung function at 11 years of age. J Paediatr Child Health 1996;32:339-43.
54. Northway WH Jr., Moss RB, Carlisle KB et al. Late pulmonary sequelae of bronchopulmonary dysplasia see comments. New Engl J Med 1990;323:1793-9.
55. Andreasson B, Lindroth M, Mortensson W et al. Lung function eight years after neonatal ventilation. Arch Dis Child 1989; 64:108-13.
56. Bader D, Ramos AD, Lew CD et al. Childhood sequelae of infant lung disease: exercise and pulmonary function abnormalities after bronchopulmonary dysplasia. J Pediatr 1987; 110:693-9.
57. de Kleine MJ, Roos CM, Voorn WJ et al. Lung function 8-18 years after intermittent positive pressure ventilation for hyaline membrane disease see comments. Thorax 1990; 45:941-6.
58. Giacoia GP, Venkataraman PS, West-Wilson KI et al. Follow-up of school-age children with bronchopulmonary dysplasia. J Pediatr 1997;130:400-8.
59. Gross SJ, Iannuzzi DM, Kveselis DA et al. Effect of preterm birth on pulmonary function at school age: a prospective controlled study see comments. J Pediatr 1998;133:188-92.
60. Hakulinen AL, Heinonen K, Lansimies E et al. Pulmonary function and respiratory morbidity in school-age children born prematurely and ventilated for neonatal respiratory insufficiency. Pediatr Pulmonol 1990;8:226-32.
61. Hakulinen AL, Jarvenpaa AL, Turpeinen M et al. Diffusing capacity of the lung in school-aged children born very preterm, with and without bronchopulmonary dysplasia. Pediatr Pulmonol 1996;21:353-60.
62. Jacob SV, Coates AL, Lands LC et al. Long-term pulmonary sequelae of severe bronchopulmonary dysplasia [see comments]. J Pediatr 1998;133:193-200.
63. MacKenzie C. Very low birth weight survivors: functional status at 8-10 years. Sheffield, MD: Sheffield 1992.
64. Mitchell SH, Teague WG. Reduced gas transfer at rest and during exercise in school-age survivors of bronchopulmonary dysplasia. Am J Respir Crit Care Med 1998;157:1406-12.
65. Pianosi PT, Fisk M. Cardiopulmonary exercise performance in prematurely born children. Pediatr Res 2000;47:653-8.
66. Peikonen AS, Hakulinen AL, Turpeinen M. Bronchial lability and responsiveness in school children born very preterm. Am J Respir Crit Care Med 1997;156:1178-84.
67. Santuz P, Baraldi E, Zaramella P et al. Factors limiting exercise performance in long-term survivors of bronchopulmonary dysplasia. Am J Respir Crit Care Med 1995; 152:1284-9.
68. Doyle L, Cheung M, Ford G et al. Birth weight <1501 g and respiratory health at age 14. Arch Dis Child 2001;84:40-4.
69. Smyth JA, Tabachnik E, Duncan WJ et al. Pulmonary function and bronchial hyperreactivity in long-term survivors of bronchopulmonary dysplasia. Pediatrics 1981;68:336-40.
70. Parat S, Moriette G, Delaperche MF et al. Long-term pulmonary functional outcome of bronchopulmonary dysplasia and premature birth. Pediatr Pulmonol 1995;20:289-96.
71. Jacob SV, Lands LC, Coates AL et al. Exercise ability in survivors of severe bronchopulmonary dysplasia. Am J Respir Crit Care Med 1997;155:1925-9.
72. Kinali M, Greenough A, Dimitriou G et al. Chronic respiratory morbidity following premature delivery-prediction by prolonged respiratory support requirement? Eur J Pediatr 1999; 158:493-6.
73. Chye JK, Gray PH. Rehospitalization and growth of infants with bronchopulmonary dysplasia: a matched control study. J Paediatr Child Health 1995;31:105-11.
74. Korhonen P, Koivisto AM, Ikonen S et al. Very low birthweight, bronchopulmonary dysplasia and health in early childhood. Acta Paediatr 1999;88:1385-91.